|
|
||||||||




*
Department of Microbiology, Boston University School of Medicine, Boston, MA 02118; and Departments of
Immunology and
Medicine, Duke University Medical Center, Durham, NC 27710
Secreted IgM is predominantly found as pentameric molecules, but IgM can also be secreted as hexamers by B cell lines. Murine hexamers activate the complement cascade more efficiently than pentamers, but the physiologic significance of hexameric IgM remains unknown. Here, we report that IgM hexamers and pentamers are cleared from the circulation with similar kinetics, suggesting that the predominance of pentameric IgM in vivo reflects the regulation of polymer assembly and secretion in responding B cells. Normal IgM-secreting B cells, particularly those from the peritoneal cavity, are capable of secreting abundant hexameric IgM in vitro. The disparity between the ability of B cells to secrete IgM hexamers in vitro and the paucity of this polymer in vivo suggest that IgM hexamers might be deleterious. In support of this, we demonstrate that the autoantibodies from a number of patients with cold agglutinin (CA) disease include both IgM hexamers and pentamers. The CA IgM hexamers lyse human erythrocytes in the presence of human complement more efficiently than CA IgM pentamers, suggesting a potential role for hexameric IgM in the pathogenesis of this autoimmune syndrome.
This article has been cited by other articles:
![]() |
Y. Chen, Y.-B. Park, E. Patel, and G. J. Silverman IgM Antibodies to Apoptosis-Associated Determinants Recruit C1q and Enhance Dendritic Cell Phagocytosis of Apoptotic Cells J. Immunol., May 15, 2009; 182(10): 6031 - 6043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Gunn and J. W. Brewer Evidence That Marginal Zone B Cells Possess an Enhanced Secretory Apparatus and Exhibit Superior Secretory Activity J. Immunol., September 15, 2006; 177(6): 3791 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Rosse, P. Hillmen, and A. D. Schreiber Immune-Mediated Hemolytic Anemia Hematology, January 1, 2004; 2004(1): 48 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Michaelsen, O. Ihle, K. J. Beckstrom, T. K. Herstad, J. Kolberg, E. A. Hoiby, and A. Aase Construction and Functional Activities of Chimeric Mouse-Human Immunoglobulin G and Immunoglobulin M Antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 Epitopes Infect. Immun., October 1, 2003; 71(10): 5714 - 5723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Shin, J. S. Lin, P. W. Anderson, R. A. Insel, and M. H. Nahm Monoclonal Antibodies Specific for Neisseria meningitidis Group B Polysaccharide and Their Peptide Mimotopes Infect. Immun., May 1, 2001; 69(5): 3335 - 3342. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Heckenlively, A. A. Fawzi, J. Oversier, B. L. Jordan, and N. Aptsiauri Autoimmune Retinopathy: Patients With Antirecoverin Immunoreactivity and Panretinal Degeneration Arch Ophthalmol, November 1, 2000; 118(11): 1525 - 1533. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sorensen, I. B. Rasmussen, V. Sundvold, T. E. Michaelsen, and I. Sandlie Structural requirements for incorporation of J chain into human IgM and IgA Int. Immunol., January 1, 2000; 12(1): 19 - 27. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |